Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04487106
Title	Azacitidine, Venetoclax, and Trametinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	M.D. Anderson Cancer Center
Indications	myelodysplastic syndrome acute myeloid leukemia chronic myelomonocytic leukemia
Therapies	Azacitidine + Trametinib + Venetoclax
Age Groups:	senior \| adult
Covered Countries	USA